98%
921
2 minutes
20
Background: The etiology of acute kidney injury (AKI) can be divided into pre-renal, renal, and post-renal causes. Ultrasound is the test of choice to identify post-renal AKI. While ultrasound is routinely used in the assessment of AKI, obstructive AKI is rare, leading to concerns of potential test overutilization.
Objective: Our primary aim is to describe patterns of use of imaging in patients admitted to hospital with AKI and to determine whether imaging patterns reflect risk of obstruction. Our secondary aim is to identify the role of point-of-care ultrasound (POCUS) when assessing patients with AKI.
Design: This is a retrospective cohort study.
Participants: Patients admitted to internal medicine with AKI over a 12-month period at a large tertiary care academic center.
Main Measures: Our outcome variables were radiology-performed ultrasound, computed tomography (CT), or point-of-care ultrasound (POCUS), presence or absence of hydronephrosis and urological intervention.
Key Results: The proportion of patients with imaging was highest among those with a high-risk score and lowest in patients with a low-risk score (66.0% versus 52.2%). For radiology ultrasound specifically, the rate was 19.5% in low-risk patients and 17.7% in high-risk patients. The prevalence of hydronephrosis among patients at low, moderate and high risk for hydronephrosis was 7.1%, 8.5% and 19.7%, respectively and the rate of urological intervention was 1.4%, 1.2% and 3.8%, respectively. In moderate to high-risk patients, POCUS had a sensitivity of 86.7% and specificity of 90.0% for the identification of hydronephrosis.
Conclusions: In our cohort, nearly 20% of radiology ultrasounds are ordered in patients with a low risk of obstructive uropathy, despite low rates of hydronephrosis and hydronephrosis requiring intervention in this group. With a sensitivity of 86.7% and specificity of 90.0% in patients at moderate to high risk of obstruction, POCUS may support clinical decision making in patients with AKI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11606-025-09704-2 | DOI Listing |
Eur J Radiol
September 2025
Department of Radiology, Affiliated Hospital of Hebei University, Baoding 071000, China. Electronic address:
Purpose: The present study aimed to develop a noninvasive predictive framework that integrates clinical data, conventional radiomics, habitat imaging, and deep learning for the preoperative stratification of MGMT gene promoter methylation in glioma.
Materials And Methods: This retrospective study included 410 patients from the University of California, San Francisco, USA, and 102 patients from our hospital. Seven models were constructed using preoperative contrast-enhanced T1-weighted MRI with gadobenate dimeglumine as the contrast agent.
Pathol Res Pract
September 2025
Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China. Electronic address:
Background: Dermal clear cell sarcoma (DCCS) is a rare malignant mesenchymal neoplasm. Owing to the overlaps in its morphological and immunophenotypic profiles with a broad spectrum of tumors exhibiting melanocytic differentiation, it is frequently misdiagnosed as other tumor entities in clinical practice. By systematically analyzing the clinicopathological characteristics, immunophenotypic features, and molecular biological properties of DCCS, this study intends to further enhance pathologists' understanding of this disease and provide a valuable reference for its accurate diagnosis.
View Article and Find Full Text PDFPathol Res Pract
September 2025
Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Electronic address:
Our research aims to ascertain the value of precursor and outgrowth lepidic in aiding the confirmation of multiple lung adenocarcinomas as separate primary lung cancers (SPLC). A total of 151 patients with metachronous multiple invasive adenocarcinomas were included in this study. Driver mutation tests(at least five genes: EGFR, ALK, KRAS, BRAF, and ROS1) were conducted on 302 tumors collected from 151 patients.
View Article and Find Full Text PDFJ Crit Care
September 2025
Neuro-Intensive Care Unit, Department of Neurosurgery, Clinical Medical College, Yangzhou University, Yangzhou, China; Neuro-intensive Care Unit, Department of Neurosurgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China. Electronic address:
J Crit Care
September 2025
Neuro-Intensive Care Unit, Department of Neurosurgery, Clinical Medical College, Yangzhou University, Yangzhou, China; Neuro-intensive Care Unit, Department of Neurosurgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China. Electronic address: